BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29317039)

  • 21. Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy: Initial Results.
    Wang C; Horton JK; Yin FF; Chang Z
    Technol Cancer Res Treat; 2016 Oct; 15(5):651-60. PubMed ID: 26134438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abbreviated MRI and Accelerated MRI for Screening and Diagnosis of Breast Cancer.
    Sheth D; Abe H
    Top Magn Reson Imaging; 2017 Oct; 26(5):183-189. PubMed ID: 28961567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V; Ravaioli S; Vacondio R; Coriani C; Caffarri S; Sghedoni R; Nitrosi A; Ragazzi M; Gasparini E; Masini C; Bisagni G; Falco G; Ferrari G; Braglia L; Del Prato A; Malavolti I; Ginocchi V; Pattacini P
    Breast Cancer Res; 2017 Sep; 19(1):106. PubMed ID: 28893303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for breast cancer detection: a meta-analysis.
    Zhang L; Tang M; Min Z; Lu J; Lei X; Zhang X
    Acta Radiol; 2016 Jun; 57(6):651-60. PubMed ID: 26275624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of dynamic contrast-enhanced screening breast MRI in populations at increased risk for breast cancer.
    Gillman J; Toth HK; Moy L
    Womens Health (Lond); 2014 Nov; 10(6):609-22. PubMed ID: 25482488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging in breast cancer: magnetic resonance imaging.
    Lehman CD; Schnall MD
    Breast Cancer Res; 2005; 7(5):215-9. PubMed ID: 16168141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abbreviated protocol breast MRI: The past, present, and future.
    Greenwood HI
    Clin Imaging; 2019; 53():169-173. PubMed ID: 30366213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging and breast ultrasonography as an adjunct to mammographic screening in high-risk patients.
    Le-Petross HT; Shetty MK
    Semin Ultrasound CT MR; 2011 Aug; 32(4):266-72. PubMed ID: 21782116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Future applications and innovations of clinical breast magnetic resonance imaging.
    Partridge SC
    Top Magn Reson Imaging; 2008 Jun; 19(3):171-6. PubMed ID: 18941397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contrast Enhanced Spectral Mammography: A Review.
    Patel BK; Lobbes MBI; Lewin J
    Semin Ultrasound CT MR; 2018 Feb; 39(1):70-79. PubMed ID: 29317041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications.
    DeMartini W; Lehman C; Partridge S
    Acad Radiol; 2008 Apr; 15(4):408-16. PubMed ID: 18342764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast MRI: Is Faster Better?
    Milon A; Wahab CA; Kermarrec E; Bekhouche A; Taourel P; Thomassin-Naggara I
    AJR Am J Roentgenol; 2020 Feb; 214(2):282-295. PubMed ID: 31825262
    [No Abstract]   [Full Text] [Related]  

  • 33. Emerging techniques and molecular imaging in breast cancer.
    Yang WT
    Semin Ultrasound CT MR; 2011 Aug; 32(4):288-99. PubMed ID: 21782119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Indications of the Magnetic Resonance Method in Breast Pathology.
    Chiriţă A
    Chirurgia (Bucur); 2017; 112(4):367-377. PubMed ID: 28862112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can diffusion-weighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy in patients with breast cancer?
    Wu LM; Hu JN; Gu HY; Hua J; Chen J; Xu JR
    Breast Cancer Res Treat; 2012 Aug; 135(1):17-28. PubMed ID: 22476850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abbreviated MRI Protocols in Breast Cancer Diagnostics.
    Deike-Hofmann K; Koenig F; Paech D; Dreher C; Delorme S; Schlemmer HP; Bickelhaupt S
    J Magn Reson Imaging; 2019 Mar; 49(3):647-658. PubMed ID: 30328180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-surgical Multiparametric Assessment of Breast Lesions Using 3-Tesla Magnetic Resonance.
    Mirka H; Tupy R; Narsanska A; Hes O; Ferda J
    Anticancer Res; 2017 Dec; 37(12):6965-6970. PubMed ID: 29187481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction of an abbreviated breast MRI service in the UK as part of the BRAID trial: practicalities, challenges, and future directions.
    Vinnicombe S; Harvey H; Healy NA; Papalouka V; Schiller A; Moyle P; Kilburn-Toppin F; Allajbeu I; Sharma N; Maxwell AJ; Payne N; Graves M; Gilbert FJ
    Clin Radiol; 2021 Jun; 76(6):427-433. PubMed ID: 33712291
    [No Abstract]   [Full Text] [Related]  

  • 39. The diagnostic sensitivity of dynamic contrast-enhanced magnetic resonance imaging and breast-specific gamma imaging in women with calcified and non-calcified DCIS.
    Kim JS; Lee SM; Cha ES
    Acta Radiol; 2014 Jul; 55(6):668-75. PubMed ID: 24043881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of neoadjuvant chemotherapeutic response of locally advanced breast cancer by magnetic resonance imaging.
    Abraham DC; Jones RC; Jones SE; Cheek JH; Peters GN; Knox SM; Grant MD; Hampe DW; Savino DA; Harms SE
    Cancer; 1996 Jul; 78(1):91-100. PubMed ID: 8646731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.